Search Results - "Guerrero, Lisa J."
-
1
Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone
Published in PloS one (16-09-2011)“…Secreted Protein Acidic and Rich in Cysteine (SPARC) is one of the major non-structural proteins of the extracellular matrix (ECM) in remodeling tissues. The…”
Get full text
Journal Article -
2
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
Published in Molecular cancer (04-06-2010)“…New, more effective strategies are needed to treat highly aggressive neuroblastoma. Our laboratory has previously shown that full-length Secreted Protein…”
Get full text
Journal Article -
3
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
Published in BMC cancer (14-06-2010)“…Epigenetic aberrations and a CpG island methylator phenotype have been shown to be associated with poor outcomes in children with neuroblastoma (NB). Seven…”
Get full text
Journal Article -
4
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids
Published in Oncotarget (22-11-2016)“…SPARC is a matrix protein that mediates interactions between cells and the microenvironment. In cancer, SPARC may either promote or inhibit tumor growth…”
Get full text
Journal Article -
5
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix
Published in International journal of cancer (15-01-2006)“…Secreted protein, acidic and rich in cysteine (SPARC), is a multifunctional matricellular glycoprotein. In vitro, SPARC has antiangiogenic properties,…”
Get full text
Journal Article -
6
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth
Published in Pediatric blood & cancer (01-10-2012)“…Background More effective therapy for children with high‐risk neuroblastoma is desperately needed. Preclinical studies have shown that neuroblastoma tumor…”
Get full text
Journal Article -
7
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth
Published in Pediatric blood & cancer (01-01-2011)“…The quinoxaline anti‐tumor agent (R+)XK469 mediates its effects by topoisomerase IIB inhibition. This report describes a 14‐year old with relapsed…”
Get full text
Journal Article -
8
The Quinoxaline Antitumor Agent (R+)XK469 Inhibits Neuroblastoma Tumor Growth
Published in Pediatric blood & cancer (01-01-2011)“…The quinoxaline antitumor agent (R+)XK469 mediates its effects by topoisomerase IIB inhibition. This report describes a 14 year-old with relapsed neuroblastoma…”
Get full text
Journal Article